Value of Infection Control Programs on Infection Associated with Urinary Tract Catheterization in Sohag University Hospital (Urinary tract)

March 5, 2025 updated by: Mohamed Mosleh, Sohag University
The aim of this study is to evaluate the effectiveness of an infection control program implemented at Sohag University Hospital in reducing the incidence of catheter-associated urinary tract infections (CAUTIs) among patients requiring urinary catheterization.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Mohamed mahmoud mohamed Mosleh, MBBCH
  • Phone Number: 00201003565342
  • Email: nmosleh41@gmail.com

Study Locations

  • Egypt
      • Sohag, Egypt, 82738
        • Recruiting
        • Sohag university hospitals
        • Contact:
          • Laila Mohamed Yousef, professor of clinica pathology
          • Phone Number: 00201002976973
          • Email: lelysaeed@yahoo.com

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

Adult patients (≥ 18 years) who are catheterized during their hospitalization. Patients who provide informed consent to participate in the study.

Exclusion Criteria:

Patients with a known history of urinary tract infections prior to hospitalization.

Patients who have indwelling catheters for more than 14 days before the study. Patients with urinary tract anomalies or other conditions that may affect infection rates.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Patients with urinary catheters
Adult patients (≥ 18 years) who are catheterized during their hospitalization.
Procedure: urinary catheterization
urine samples for culture and sensitivity will be collected in patients having urinary tract infection and we will use sterile container 50cc for urine sampling culture on blood or macconkey medium for detection type of organism .

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of CAUTIs:
Time Frame: one month
The primary outcome will be the rate of CAUTIs before and after the implementation of the infection control program. CAUTIs will be defined according to the criteria established by the Centers for Disease Control and Prevention (CDC) and will include clinical signs, symptoms, and positive urine cultures.
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Length of Hospital Stay:
Time Frame: one month
The average length of stay for patients with CAUTIs will be compared preand post-intervention. A reduction in length of stay may indicate improved patient outcomes and decreased complications.
one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sohag University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2025

Primary Completion (Estimated)

June 30, 2025

Study Completion (Estimated)

August 1, 2025

Study Registration Dates

First Submitted

February 28, 2025

First Submitted That Met QC Criteria

March 4, 2025

First Posted (Actual)

March 25, 2025

Study Record Updates

Last Update Posted (Actual)

March 25, 2025

Last Update Submitted That Met QC Criteria

March 5, 2025

Last Verified

February 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • Soh-Med--25-2-01MS

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on UTI

Clinical Trials on urinary catheterization

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe